Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hubei Tiansheng Pharmaceutical Co., Ltd. is a Chinese pharmaceutical manufacturer and a key subsidiary of the Tiansheng Pharmaceutical Group. The company specializes in the development, production, and sale of both chemical pharmaceuticals and Traditional Chinese Medicines (TCM). Its product portfolio is diverse, encompassing large-volume parenteral infusions, small-volume injections, and various oral solid dosage forms like tablets and capsules. Hubei Tiansheng focuses on several major therapeutic areas, including cardiovascular, respiratory, and anti-infective medicine. Operating out of Hubei province, the company utilizes GMP-compliant manufacturing lines to supply the domestic Chinese market with essential medications.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hubei Tiansheng Pharmaceutical.